












httpProspective, randomized study of cutting balloon
angioplasty versus conventional balloon angioplasty
for the treatment of hemodialysis access stenoses
Hossam M. Saleh, MD, MRCS,a Ahmed K. Gabr, MD, MRCS,a Mohamed M. Tawﬁk, MD,a and
Hesham Abouellail, MD,b Cairo, Egypt
Objective: The aim of this trial was to compare the rates of patency achieved by cutting and conventional balloon an-
gioplasty to treat hemodialysis access stenoses.
Methods: End-stage renal failure patients (at three tertiary referral centers) with signiﬁcant hemodialysis access stenoses
were prospectively randomized to have percutaneous transluminal angioplasty (PTA) by either cutting or conventional
balloons. Patients with more than one hemodynamically signiﬁcant stenosis were excluded. Kaplan-Meier method was
used to compare the primary assisted patency rates for the two groups.
Results: The study randomized 623 patients into two groups, and the duration of follow-up was 15 6 3 months. In
the cutting balloon angioplasty group, the clinical success rate was 89% (282 of 316 stenoses). In the conventional
balloon angioplasty group, the clinical success rate was 86% (265 of 307 stenoses; P [ .637). Assisted primary
patency for cutting PTA was statistically signiﬁcantly higher at 6 months and 1 year (86% and 63%) than that for
conventional PTA (56% and 37%, respectively; P [ .037) in the treatment of stenosis of the graft-to-vein anasto-
mosis. In the venous stenosis subgroup, equivalent primary assisted patency at 6 months and 1 year was observed for
cutting PTA (84% and 55%) and conventional PTA (70% and 46%, respectively; P [ .360). In the intragraft stenosis
subgroup, primary assisted patency was equivalent at 6 months and 1 year for cutting PTA (67% and 39%) and
conventional PTA (62% and 49%, respectively; P [ .371). In the arterial anastomotic stenosis subgroup, assisted
primary patency at 6 months and 1 year was equivalent for cutting PTA (70% and 30%) and conventional PTA (75%
and 33%, respectively; P [ .921).
Conclusions: Cutting balloon angioplasty proved to be a safe and effective treatment of graft-to-vein anastomotic stenosis,
with signiﬁcantly higher patency than that of conventional balloon angioplasty. (J Vasc Surg 2014;60:735-40.)Maintenance of long-term patency of hemodialysis
vascular access is essential for regular hemodialysis in end-
stage renal failure patients. Hemodialysis access failure
may occur by thrombosis secondary to stenosis of the anas-
tomosis or the draining vein. Such patients usually need
multiple interventions to restore functionality; otherwise,
they would require creation of another hemodialysis access.
The use of percutaneous transluminal angioplasty (PTA) to
treat signiﬁcant stenosis of hemodialysis access is recom-
mended to prolong the patency of both autogenous arte-
riovenous ﬁstulas and prosthetic arteriovenous grafts.1-5
Repeated angioplasty procedures may be necessary to
maintain secondary patency of failing hemodialysis access.2
It is assumed that techniques that improve the patency of
arteriovenous ﬁstulas and grafts will limit the number ofthe Department of Vascular Surgerya andDepartment of Nephrology,b
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The aim of this trial was to compare the patency achieved
by cutting and conventional balloon angioplasty to treat
hemodialysis access stenoses.
METHODS
The study was performed at three tertiary referral cen-
ters in the Middle East (Prince Salman Hospital, Tabuk;
Saudi German Hospital, Riyadh; and Al-Hassa Hospital).
Our institutional review board approved the study proto-
col, and written informed consent was obtained from all
patients.
Study design. Patients with different types of hemo-
dialysis access stenoses in whom PTA was indicated were
prospectively randomized (by a sealed envelope random-
ization service6) into two groups, one group treated with
cutting balloon angioplasty and the other group treated
with conventional balloon angioplasty. Table I outlines
the demographics of the study population. The treating
vascular surgeon evaluated the indication for angioplasty,
performed the angioplasty, and monitored the clinical
course after angioplasty. Procedural details recorded
included access type, location, details of the angioplasty
procedure, procedure outcome, and complications.
Patients were monitored for angioplasty-related compli-
cations, including balloon rupture, vessel injury, aneu-
rysm formation, bleeding, reaction to contrast material,735
Table I. Demographic characteristics of the study
population
Characteristic Cutting balloon, % Conventional, %
Age, years
Mean 6 SD 60.4 6 10 61.9 6 10
Range 43-79 41-75
Female sex 41 55
Diabetes mellitus 56 49
Hypertension 85 82
Coronary artery disease 24 26
Congestive heart failure 7 9
SD, Standard deviation.
Table II. Exclusion criteria
Previous PTA for the same lesion
PTA combined with stenting
Associated signiﬁcant (>50%) central venous stenosis
Multiple signiﬁcant (>50%) stenoses
Previous access thrombectomy
Positive pregnancy test result within 7 days before enrollment
Patient is scheduled for a kidney transplant
Life expectancy <6 months
Allergy to heparin or radiographic contrast material
PTA, Percutaneous transluminal angioplasty.
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and death.
Inclusion criteria. PTAs were performed in end-stage
renal failure patients with hemodynamically signiﬁcant
(deﬁned as >50%) stenosis of the autogenous ﬁstula or
prosthetic graft.
Exclusion criteria. Exclusion criteria are listed in
Table II.
Assessment of stenoses. Screening was done by ultra-
sonography, with angiography reserved for patients with
hemodynamically signiﬁcant stenoses, to assess the degree
and location of stenosis as well as to delineate the outﬂow
veins. All lesions were characterized by location, length,
and degree of stenosis. The angiographic criteria were
assessed and satisﬁed before any treatment was performed.
The target lesion was imaged in two orthogonal planes.
The imaging plane that demonstrated the greatest percent-
age of stenosis was used for anatomic measurements. The
diameter of the adjacent segment of normal vein was
used as the reference diameter. The percentage of stenosis
was deﬁned as the maximum diameter reduction compared
with the reference vessel diameter (Table III).
Procedures and criteria for success. The vascular sur-
geon performed all procedures with local anesthesia
(lidocaine 2%). Heparin (2000 IU) was administered intra-
venously at the beginning of each procedure. Balloon size
was determined according to the measured diameter of the
reference vessel or the prosthetic graft. An introducer
sheath (5F-7F) was used as an access for angioplasty in
all patients.
Technique of PTA. The technique of cutting PTA
and the technique of conventional PTA are detailed in
the Appendix.
Total procedure time. The total procedure time was
documented for each patient. The start of the procedure
was deﬁned as the moment when the physician gained
percutaneous access into the hemodialysis access. The
end of the procedure was determined by the time of
completion of ﬁnal postprocedural ﬁstulography.
Deﬁnitions. Clinical success was deﬁned as resump-
tion of at least one session of normal dialysis after angio-
plasty. Hemodynamic success was deﬁned as restoration
of normal blood ﬂow through the treated vascular lesion.
Anatomic success was deﬁned as residual stenosis <30%after angioplasty. Successful endovascular intervention was
based on these clinical, hemodynamic, and anatomic end
points. Assisted primary patency was deﬁned as maintained
patency of the treated lesion after angioplasty. Hemodialysis
access failure due to restenosis of the treated lesion was
considered the end point of assisted primary patency.
Follow-up. Follow-up included clinical examination,
dialysis access venous pressure measurement during dial-
ysis, and measurements of dialysis access recirculation,
performed every 4 weeks. Measurement of the hemodialy-
sis access ﬂow with ultrasonography was done every
12 weeks. Fistulography was performed when a stenosis
of >50% was detected by ultrasonography.
Statistical analysis. The degree of stenosis before
angioplasty, residual stenosis after angioplasty, diameter
improvement after angioplasty, and diameter of the balloon
used in the cutting and conventional balloon angioplasty
groups were compared by Mann-Whitney U test. The
four types of hemodialysis access stenoses evaluated in our
study were located in the venous outﬂow, at the graft-to-
vein anastomosis, within the graft, and at the arterial
anastomosis. Venous stenosis was deﬁned as stenosis of the
ﬁstula vein from the arteriovenous anastomosis to the
central veins (but not including central vein stenosis). The
assisted primary patency for these four types of stenoses was
assessed by Kaplan-Meier analysis. The log-rank test was
used to compare the cutting and conventional PTA groups
to determine statistical signiﬁcance. P values < .05 were
considered statistically signiﬁcant. Statistical analysis was
performed with Stat-View version 5.0 software (SAS
Institute Inc, Cary, NC).
RESULTS
The study prospectively randomized 623 patients with
the four described types of hemodialysis access stenoses in
whom PTA was indicated into two groups to receive cut-
ting balloon angioplasty or conventional balloon angio-
plasty. The mean duration of follow-up was 15 6
3 months.
Cutting balloon angioplasty group. From January
2012 to December 2013, 316 patients (185 men, 131
women) with 316 stenoses underwent cutting PTA. The
316 stenoses consisted of 95 venous, 80 graft-to-vein
anastomosis, 61 intragraft, and 80 arterial anastomotic
stenoses; 282 patients (89%) achieved clinical success with
Table III. Percentage diameter stenosis before percutaneous transluminal angioplasty (PTA), residual percentage


























Venous 80.9 6 12 74.1 6 14 .041 30.8 6 15 26.8 6 13 .328 50.1 6 12 47.3 6 11 .312
Graft-to-vein anastomotic 82.1 6 16 67.9 6 13 .060 34.9 6 12 32.0 6 12 .372 47.2 6 13 35.9 6 12 .041
Intragraft 68.1 6 18 63.0 6 9.5 .858 38.9 6 16 27.9 6 8.7 .028 29.2 6 14 35.1 6 11 .287
Arterial anastomotic 74.8 6 5.5 72.1 6 6.1 .327 34.9 6 11 24.1 6 15 .096 39.9 6 16 48 6 10 .141
aP values were derived from comparisons between cutting and conventional PTA groups and were calculated with the Mann-Whitney U test.
Table IV. Diameter and loaded maximum pressure of balloons
Stenosis type
Inﬂation diameter of balloon, mm Loaded maximum pressure, atm
Cutting PTA Conventional PTA P valuea Cutting PTA Conventional PTA P valuea
Venous 5.6 6 0.6 5.4 6 0.5 .862 6.0 6 4.0 15.1 6 2.2 .041
Graft-to-vein anastomotic 5.2 6 0.2 5.1 6 0.4 .480 6.1 6 2.2 15.5 6 3.2 .043
Intragraft 5.4 6 0.3 5.5 6 0.6 .487 8.2 6 2.0 16.7 6 2.6 0.48
Arterial anastomotic 2.5 6 0.4 2.8 6 0.3 .775 8.4 6 2.6 15.0 6 2.0 .049
aP values were derived from comparisons between cutting and conventional PTA groups and were calculated with the Mann-Whitney U test.
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clinical success in 34 patients; these patients required stent
implantation (12 patients) or surgical intervention (22
patients).
Conventional balloon angioplasty group. From
January 2012 to December 2013, 307 patients (137
men, 170 women) with 307 stenoses underwent conven-
tional PTA. The 307 stenoses consisted of 81 venous, 82
graft-to-vein anastomosis, 72 intragraft, and 72 arterial
anastomotic stenoses; 265 patients (86%) achieved clinical
success with conventional PTA. Conventional balloon an-
gioplasty failed to achieve clinical success in 42 patients;
these patients required stent implantation (15 patients),
surgical reconstruction (17 patients), or graft insertion (10
patients).
Cutting and conventional balloon angioplasty
groups. The mean time of the angioplasty procedure for
cutting and conventional balloon angioplasty was 61.2 mi-
nutes and 49.6 minutes, respectively (P ¼ .642). Differ-
ences in the degree of stenosis before angioplasty and the
diameter of the balloon used between cutting and conven-
tional balloon angioplasty were not statistically signiﬁcant
for all subgroups (Tables III and IV). Statistically insig-
niﬁcant differences between cutting and conventional
balloon angioplasty were seen with regard to residual ste-
nosis after angioplasty in the subgroups for venous stenosis
(P ¼ .328), stenosis of the graft-to-vein anastomosis (P ¼
.371), and arterial anastomotic stenosis (P ¼ .096). Dif-
ferences in the clinical success rates were statistically
insigniﬁcant between cutting balloon angioplasty (89%)
and conventional balloon angioplasty (86%) groups
(P ¼ .637). Differences in the percentage diameterimprovement after angioplasty were statistically signiﬁ-
cant in favor of the cutting balloon for the subgroup with
stenosis of the graft-to-vein anastomosis (P ¼ .041).
Differences in percentage diameter improvement be-
tween the cutting and conventional balloon angioplasty
groups were not statistically signiﬁcant after angioplasty
in the subgroups with venous stenosis (P ¼ .312),
intragraft stenosis (P ¼ .287), and arterial anastomotic
stenosis (P ¼ .141). The degree of stenosis before an-
gioplasty, residual stenosis after angioplasty, and diameter
improvement after angioplasty are illustrated in Table III.
The balloon diameter and the inﬂation pressure used are
provided in Table IV.
For the venous stenosis subgroup, by Kaplan-Meier
analysis, the assisted primary patency at 6 months and
1 year for the cutting balloon angioplasty group was
84% and 55%, respectively, compared with 70% and
46%, respectively, for conventional balloon angioplasty.
These differences did not reach statistical signiﬁcance
(P ¼ .360) (Fig 1).
However, for the graft-to-vein anastomotic subgroup,
the assisted primary patency for the cutting balloon angio-
plasty group (86% and 63% at 6 months and 1 year, respec-
tively) was signiﬁcantly better than that for the
conventional balloon angioplasty group (56% and 37%;
P ¼ .037) (Fig 2).
For the intragraft stenosis subgroup, the assisted
primary patency for the cutting balloon angioplasty group
(67% and 39% at 6 months and 1 year, respectively)
and the conventional balloon angioplasty group (75%
and 33%) was not statistically signiﬁcantly different
(P ¼ .371) (Fig 3).
Fig 1. Graph shows the Kaplan-Meier survival analysis for assisted
primary patency rates in patients with venous stenosis in the cut-
ting and conventional percutaneous transluminal angioplasty
(PTA) groups. No signiﬁcant differences in assisted primary
patency rates were identiﬁed between groups (P ¼ .360). The
number of patients at risk in each time period is listed.
Fig 2. Graph shows the Kaplan-Meier survival analysis for assisted
primary patency rates in patients with graft-to-vein anastomotic
stenosis in the cutting and conventional percutaneous transluminal
angioplasty (PTA) groups. The assisted primary patency rate was
signiﬁcantly higher in the cutting PTA group than in the con-
ventional PTA group (P ¼ .037). Note that the line is interrupted
beyond the point at which standard error exceeds 10%. The
number of patients at risk in each time period is listed.
Fig 3. Graph shows the Kaplan-Meier survival analysis for assisted
primary patency rates in patients with intragraft stenosis in the
cutting and conventional percutaneous transluminal angioplasty
(PTA) groups. No signiﬁcant differences in assisted primary
patency rates were identiﬁed between groups (P ¼ .371). The
number of patients at risk in each time period is listed.
Fig 4. Graph shows the Kaplan-Meier survival analysis for assisted
primary patency rates in patients with arterial anastomotic stenosis
in the cutting and conventional percutaneous transluminal angio-
plasty (PTA) groups. No signiﬁcant differences in assisted primary
patency rates were identiﬁed between groups (P ¼ .921). Note
that the line is interrupted beyond the point at which standard
error exceeds 10%. The number of patients at risk in each time
period is listed.
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group, the assisted primary patency for the cutting balloon
angioplasty group (70% and 30% at 6 months and 1 year,
respectively) vs the conventional balloon angioplasty group
(62% and 49%) revealed no statistically signiﬁcant differ-
ences (P ¼ .921) (Fig 4).
Complications in cutting balloon angioplasty
group. Rupture of the balloon during inﬂation occurred
in three patients with no evidence of extravasation onangiography. Angiography performed 12 weeks after an-
gioplasty showed aneurysmal dilation at the site of the
treated lesion in one of these patients. The aneurysm
was <2 cm in diameter, and no further diameter increase
could be detected at 1-year follow-up after angioplasty,
with no effect on hemodialysis. No other angioplasty-
related complications were recorded in the cutting
balloon angioplasty group.
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group. Rupture of the balloon during inﬂation occurred in
two patients, with extravasation in one successfully managed
by inﬂation of the balloon at lower pressure combined
with external manual compression for 3 minutes. No other
angioplasty-related complications were recorded in the
conventional balloon angioplasty group.
DISCUSSION
There are widespread shortcomings in the published
reports describing the use of cutting balloon angioplasty
to treat hemodialysis vascular access stenosis.7-12 First,
these studies include the concurrent use of cutting and
conventional balloon angioplasty, the use of a high pres-
sure balloon, or a combination with placement of a stent
after cutting balloon angioplasty. In other published
studies, cutting PTA was used only after failure of high-
pressure balloon angioplasty. In these reports, the long-
term patency rate is not necessarily reﬂective of the results
obtainable with cutting balloon angioplasty as a primary,
stand-alone treatment. The cutting balloon was designed
to reduce vascular trauma and thereby reduce neointimal
hyperplasia to improve hemodialysis access long-term
patency. One could theorize that concurrent use of a
high-pressure angioplasty balloon might negate these
conceptual beneﬁts. Several studies have compared cut-
ting balloon and conventional balloon angioplasty in
treatment of vascular access stenoses with conﬂicting
results.13-21
In our study, we found that the assisted primary
patency was statistically higher in favor of cutting balloon
angioplasty in contrast to conventional balloon angioplasty
in dealing with stenosis of the graft-to-vein anastomosis.
The small number of patients in the subgroups is a limita-
tion of our study, and larger future studies are warranted.
The assisted primary patency was not signiﬁcantly
improved by use of cutting balloon angioplasty for intra-
graft stenosis. Similar results were reported by Kariya
et al17 comparing cutting and conventional balloon angio-
plasty in the treatment of in-stent restenosis and intragraft
stenosis, with cutting balloon angioplasty failing to achieve
signiﬁcant improvement in assisted primary patency. Such
failure could be attributed to the resistance of the pros-
thetic graft material, which might resist cutting by the
balloon microsurgical blades.
Balloon rupture occurred in three of our patients dur-
ing cutting balloon inﬂation, with aneurysm formation at
the angioplasty site in one of these patients detected
12 weeks after angioplasty. Aneurysm formation could
be secondary to injury of the vessel wall by the cutting
balloon microsurgical blades, so patients need to be
observed for such a complication after cutting balloon
angioplasty.
CONCLUSIONS
Cutting balloon angioplasty proved to be safe and
effective in the treatment of graft-to-vein anastomoticstenosis, with signiﬁcantly higher assisted primary patency
than that of conventional balloon angioplasty.AUTHOR CONTRIBUTIONS
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